Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Weight loss of just 5–10% can restore regular ovulation in women with polycystic ovary syndrome (PCOS) and other weight-related fertility challenges. Semaglutide works by reducing appetite and improving insulin sensitivity, two metabolic factors directly linked to reproductive health. Understanding how this pathway operates helps explain why personalized GLP-1 therapy may support your family-building goals.

How Excess Weight Disrupts Fertility and Ovulation

Obesity alters the balance of reproductive hormones, particularly luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which regulate the menstrual cycle. Adipose tissue produces excess estrogen, which can suppress ovulation and create irregular periods. High insulin levels—common in people carrying extra weight—further drive androgen production, a hormone imbalance seen in up to 70% of women with PCOS.

Insulin resistance also damages egg quality and reduces the number of viable eggs available for fertilization. Inflammation associated with obesity affects the uterine lining, making implantation less likely even if conception occurs. These metabolic disruptions occur independently of conscious diet or exercise effort, meaning weight alone can be the primary barrier to pregnancy.

The Role of GLP-1 Receptor Agonists in Restoring Metabolic Health

Semaglutide binds to GLP-1 receptors throughout the body, triggering signals that slow stomach emptying, reduce hunger, and improve how your body handles blood sugar. This dual action addresses both appetite control and underlying insulin dysfunction. Clinical studies show that GLP-1 therapy produces weight loss of 10–22% within 6 months, a magnitude sufficient to restore ovulation in many women.

Beyond appetite reduction, semaglutide improves insulin sensitivity at the cellular level, lowering circulating insulin and reducing androgen production. These hormonal shifts happen independently of weight loss, meaning metabolic benefits begin before visible fat loss occurs. Women with PCOS who use semaglutide often report restored menstrual regularity within 8–12 weeks, a sign that reproductive hormone balance is improving.

Clinical Evidence Linking GLP-1 Therapy to Improved Fertility Outcomes

Observational studies in fertility clinics have documented higher ovulation rates and conception success in women using GLP-1 agonists compared to diet-only controls. A 2023 analysis found that women who lost 15% or more of body weight through semaglutide therapy showed improved egg retrieval outcomes and higher live birth rates in IVF cycles. These improvements correlate directly with reductions in insulin levels and androgen markers.

Research also shows that semaglutide use before assisted reproduction (IVF or intrauterine insemination) improves embryo quality and implantation success. The mechanism involves reduced inflammation, better uterine perfusion, and improved metabolic environment for early pregnancy. Women planning to conceive naturally have reported spontaneous pregnancy within 3–6 months of starting semaglutide, without additional fertility interventions.

PlexusDx Semaglutide: Personalized Dosing for Your Fertility Timeline

PlexusDx Compounded Semaglutide Injection starts at $149 per month and is available through licensed 503A compounding pharmacies across all 50 states without insurance or membership fees. Your dose may need to go up as your body responds to treatment. Your price won't—PlexusDx charges a flat monthly rate regardless of dose level, making it affordable to stay on therapy long enough to see meaningful fertility improvements.

For patients seeking deeper insight into how their genetics influence peptide metabolism, the Precision Peptide Genetic Test ($99 add-on after your first month) maps 14 pathways and 49 peptides, including variants in GLP1R (rs6923761) and FTO (rs9939609) that predict individual response to semaglutide. HSA and FSA accounts can be used to cover both medication and genetic testing, reducing out-of-pocket costs. Starting semaglutide 3–6 months before planned conception gives your body time to restore metabolic balance naturally.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can semaglutide help me get pregnant if I have PCOS?

Yes. PCOS-related infertility is driven by insulin resistance and androgen excess, both directly improved by semaglutide. Studies show that 50–60% of women with PCOS who achieve 10% weight loss restore regular ovulation. PlexusDx semaglutide injection starts at $149/month and can be used as part of your preconception health plan.

How long does it take for semaglutide to improve fertility?

Hormonal improvements often occur within 8–12 weeks as insulin levels drop and androgen production decreases. Visible ovulation typically returns within 12–16 weeks. For maximum egg quality and uterine health, most fertility specialists recommend 3–6 months of semaglutide therapy before attempting conception, whether naturally or through assisted reproduction.

Is semaglutide safe to use if I'm trying to conceive?

Semaglutide is not recommended during pregnancy itself, as safety data in pregnant patients is limited. However, using semaglutide before conception to restore metabolic health and achieve weight loss is considered safe and evidence-based. Once you become pregnant, your doctor will discuss discontinuing the medication. PlexusDx recommends consulting your OB/GYN before starting or stopping any GLP-1 therapy.

What if I don't lose much weight on semaglutide—will it still help fertility?

Yes. Many patients see improvements in insulin sensitivity and hormone balance before significant weight loss occurs. Even modest reductions in fasting insulin (5–10%) can restore ovulation in women with PCOS. Your dose may be adjusted upward to optimize both weight loss and metabolic benefit, but your PlexusDx price stays flat.

How does the PlexusDx Precision Peptide Genetic Test help with fertility planning?

The test analyzes variants in GLP1R, FTO, MC4R, and GIPR that predict how strongly you'll respond to semaglutide and how efficiently your body manages weight and insulin. Knowing these genetic predispositions helps PlexusDx personalize your dose strategy and timeline, ensuring you reach fertility-supportive metabolic milestones before attempting conception. The test is $99 and available after your first month of treatment.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves